Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Traws Pharma (TRAW) Return on Assets (2016 - 2025)

Traws Pharma (TRAW) has disclosed Return on Assets for 13 consecutive years, with 1.55% as the latest value for Q4 2025.

  • For Q4 2025, Return on Assets rose 685.0% year-over-year to 1.55%; the TTM value through Dec 2025 reached 1.55%, up 685.0%, while the annual FY2025 figure was 1.0%, 497.0% up from the prior year.
  • Return on Assets hit 1.55% in Q4 2025 for Traws Pharma, down from 1.12% in the prior quarter.
  • Across five years, Return on Assets topped out at 0.29% in Q4 2021 and bottomed at 10.25% in Q3 2024.
  • Average Return on Assets over 5 years is 2.18%, with a median of 0.72% recorded in 2023.
  • Year-over-year, Return on Assets tumbled -950bps in 2024 and then surged 912bps in 2025.
  • Traws Pharma's Return on Assets stood at 0.29% in 2021, then tumbled by -65bps to 0.47% in 2022, then tumbled by -73bps to 0.82% in 2023, then plummeted by -929bps to 8.4% in 2024, then skyrocketed by 82bps to 1.55% in 2025.
  • According to Business Quant data, Return on Assets over the past three periods came in at 1.55%, 1.12%, and 1.17% for Q4 2025, Q3 2025, and Q2 2025 respectively.